Chemical M&A – The Devil is in the Details (Y&P Article – ICIS Chemical Business May 26 – June 1, 2014 issue)
Young & Partners authors article explaining the unusual underlying factors driving the M&A market
Chemicals M&A Steady in First Quarter – Chemical Week (May 19-26, 2014)
Peter Young of Young & Partners interviewed about the factors behind the strong M&A market
Chemical M&A strength in 2013 expected to continue (Chemical Week March 3, 2014 issue)
Chemical Week interviews Peter Young of Young & Partners about M&A in 2013 and 2014
Young & Partner Article – Positive M&A to Continue in 2014 (ICIS Chemical Business Feb 24, 2014 issue)
Young & Partners' view of 2013 (M&A, financial and business) and the outlook for 2014
Dow Chemical Reports a Profit – Wall Street Journal (January 29, 2014)
Young & Partners comments on shareholder activist's premise about Dow Chemical
ICIS News – Activist premise on Dow spin false (January 27, 2014)
Young & Partners disagrees with shareholder activist premise about Dow Chemical
Pharma and Biotech Financial Trends: Every Which Way (Young & Partners article written for the Pharma Exec Dec 2013 Issue)
Article summarizing the latest business, M&A and financial developments in Biopharma
Activist Investors Target Chemicals (Young & Partners article in ICIS Oct. 1 – 13, 2013)
Perspectives on what these activists try to do and how should management react?
Chemical M&A Rebound Continues (Young & Partners article in ICIS Sept 30 – Oct 6, 2013)
Young & Partners describes the factors driving the ongoing rebound
Chemical M&A Market Revives (Young & Partners article in ICIS July 15 – 28, 2013)
Young & Partners article about what is driving the current chemical M&A revival